Study pinpoints malignant mesothelioma patients likely to benefit from drug pemetrexed
Previous studies have hypothesized that low levels of the enzyme thymidylate synthase (TS) likely mark patients who will benefit from the drug pemetrexed – but results have been inconclusive at best and at times contradictory. ...
